Belviq Colon Cancer Case Survives Dismissal Motion in Ohio Federal Court



DOCUMENTS
  • Order


AKRON, Ohio — An Ohio federal magistrate judge has allowed claims for failure to warn, breach of warranty, and fraudulent misrepresentation to proceed against the makers of the weight-loss drug Belviq, ruling plaintiffs adequately alleged defendants failed to inform their doctor that it could cause colon cancer.

In a March 9 order, Magistrate Judge Carmen Henderson of the U.S. District Court for the Northern District of Ohio further found the plaintiffs sufficiently pled defendants did not adequately test the drug and fraudulently misrepresented that it was safe and effective.

Before seeking FDA approval for Belviq, Eisai Inc. and Arena Pharmaceuticals …

FIRM NAMES
  • Douglas & London
  • Porter Wright Morris & Arthur
  • Sidley Austin
  • Tucker Ellis LLP
  • Wright & Schulte





UPCOMING CONFERENCES




HarrisMartin's MDL Conference

July 27, 2022 - Seattle, WA
Fairmont Olympic Hotel, Seattle

MORE DETAILS



HarrisMartin's Midwest Asbestos Litigation Conference

September 23, 2022 - St. Louis, MO
Four Seasons Hotel, St. Louis

MORE DETAILS